5-Lipoxygenase and cysteinyl leukotriene receptor 1 regulate epidermal growth factor-induced cell migration through Tiam1 upregulation and Rac1 activation

Shigeyuki Magi, Yasushi Takemoto, Hiroki Kobayashi, Masato Kasamatsu, Takahiro Akita, Ayako Tanaka, Kei Takano, Etsu Tashiro, Yasuhiro Igarashi, Masaya Imoto

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Cell migration is an essential step for tumor metastasis. The small GTPase Rac1 plays an important role in cell migration. Previously, we reported that epidermal growth factor (EGF) induced two waves of Rac1 activation; namely, at 5 min and 12 h after stimulation. A second wave of EGF-induced Rac1 activation was required for EGF-induced cell migration, however, the spatiotemporal regulation of the second wave of EGF-induced Rac1 activation remains largely unclear. In this study, we found that 5-lipoxygenase (5-LOX) is activated in the process of EGF-induced cell migration, and that leukotriene C4 (LTC4) produced by 5-LOX mediated the second wave of Rac1 activation, as well as cell migration. Furthermore, these effects caused by LTC4 were found to be blocked in the presence of the antagonist of cysteinyl leukotriene receptor 1 (CysLT1). This blockage indicates that LTC4-mediated CysLT1 signaling regulates the second EGF-induced wave of Rac1 activation. We also found that 5-LOX inhibitors, CysLT1 antagonists and the knockdown of CysLT1 inhibited EGF-induced T cell lymphoma invasion and metastasis-inducing protein 1 (Tiam1) expression. Tiam1 expression is required for the second wave of EGF-induced Rac1 activation in A431 cells. Therefore, our results indicate that the 5-LOX/LTC4/CysLT1 signaling pathway regulates EGF-induced cell migration by increasing Tiam1 expression, leading to a second wave of Rac1 activation. Thus, CysLT1 may serve as a new molecular target for antimetastatic therapy. In addition, the CysLT1 antagonist, montelukast, which is used clinically for allergy treatment, might have great potential as a novel type of antimetastatic agent. 5-lipoxygenase (5-LOX) is activated in the process of EGF-induced cell migration, and that leukotriene C4 (LTC4) produced by 5-LOX mediated Rac1 activation and cell migration. LTC4-mediated CysLT1 signaling regulates Tiam1 expression which is required for Rac1 activation.

Original languageEnglish
Pages (from-to)290-296
Number of pages7
JournalCancer Science
Volume105
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Arachidonate 5-Lipoxygenase
Epidermal Growth Factor
Cell Movement
Up-Regulation
Leukotriene C4
Leukotriene Antagonists
montelukast
leukotriene D4 receptor
Neoplasm Metastasis
Lipoxygenase Inhibitors
Monomeric GTP-Binding Proteins
T-Cell Lymphoma
Hypersensitivity

Keywords

  • 5-Lipoxygenase
  • Cell migration
  • Cysteinyl leukotriene receptor 1
  • Epidermal growth factor signaling
  • T-cell lymphoma invasion and metastasis-inducing protein 1

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

5-Lipoxygenase and cysteinyl leukotriene receptor 1 regulate epidermal growth factor-induced cell migration through Tiam1 upregulation and Rac1 activation. / Magi, Shigeyuki; Takemoto, Yasushi; Kobayashi, Hiroki; Kasamatsu, Masato; Akita, Takahiro; Tanaka, Ayako; Takano, Kei; Tashiro, Etsu; Igarashi, Yasuhiro; Imoto, Masaya.

In: Cancer Science, Vol. 105, No. 3, 2014, p. 290-296.

Research output: Contribution to journalArticle

Magi, Shigeyuki ; Takemoto, Yasushi ; Kobayashi, Hiroki ; Kasamatsu, Masato ; Akita, Takahiro ; Tanaka, Ayako ; Takano, Kei ; Tashiro, Etsu ; Igarashi, Yasuhiro ; Imoto, Masaya. / 5-Lipoxygenase and cysteinyl leukotriene receptor 1 regulate epidermal growth factor-induced cell migration through Tiam1 upregulation and Rac1 activation. In: Cancer Science. 2014 ; Vol. 105, No. 3. pp. 290-296.
@article{0d933fcf3136467ba3770f5ee867abde,
title = "5-Lipoxygenase and cysteinyl leukotriene receptor 1 regulate epidermal growth factor-induced cell migration through Tiam1 upregulation and Rac1 activation",
abstract = "Cell migration is an essential step for tumor metastasis. The small GTPase Rac1 plays an important role in cell migration. Previously, we reported that epidermal growth factor (EGF) induced two waves of Rac1 activation; namely, at 5 min and 12 h after stimulation. A second wave of EGF-induced Rac1 activation was required for EGF-induced cell migration, however, the spatiotemporal regulation of the second wave of EGF-induced Rac1 activation remains largely unclear. In this study, we found that 5-lipoxygenase (5-LOX) is activated in the process of EGF-induced cell migration, and that leukotriene C4 (LTC4) produced by 5-LOX mediated the second wave of Rac1 activation, as well as cell migration. Furthermore, these effects caused by LTC4 were found to be blocked in the presence of the antagonist of cysteinyl leukotriene receptor 1 (CysLT1). This blockage indicates that LTC4-mediated CysLT1 signaling regulates the second EGF-induced wave of Rac1 activation. We also found that 5-LOX inhibitors, CysLT1 antagonists and the knockdown of CysLT1 inhibited EGF-induced T cell lymphoma invasion and metastasis-inducing protein 1 (Tiam1) expression. Tiam1 expression is required for the second wave of EGF-induced Rac1 activation in A431 cells. Therefore, our results indicate that the 5-LOX/LTC4/CysLT1 signaling pathway regulates EGF-induced cell migration by increasing Tiam1 expression, leading to a second wave of Rac1 activation. Thus, CysLT1 may serve as a new molecular target for antimetastatic therapy. In addition, the CysLT1 antagonist, montelukast, which is used clinically for allergy treatment, might have great potential as a novel type of antimetastatic agent. 5-lipoxygenase (5-LOX) is activated in the process of EGF-induced cell migration, and that leukotriene C4 (LTC4) produced by 5-LOX mediated Rac1 activation and cell migration. LTC4-mediated CysLT1 signaling regulates Tiam1 expression which is required for Rac1 activation.",
keywords = "5-Lipoxygenase, Cell migration, Cysteinyl leukotriene receptor 1, Epidermal growth factor signaling, T-cell lymphoma invasion and metastasis-inducing protein 1",
author = "Shigeyuki Magi and Yasushi Takemoto and Hiroki Kobayashi and Masato Kasamatsu and Takahiro Akita and Ayako Tanaka and Kei Takano and Etsu Tashiro and Yasuhiro Igarashi and Masaya Imoto",
year = "2014",
doi = "10.1111/cas.12340",
language = "English",
volume = "105",
pages = "290--296",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - 5-Lipoxygenase and cysteinyl leukotriene receptor 1 regulate epidermal growth factor-induced cell migration through Tiam1 upregulation and Rac1 activation

AU - Magi, Shigeyuki

AU - Takemoto, Yasushi

AU - Kobayashi, Hiroki

AU - Kasamatsu, Masato

AU - Akita, Takahiro

AU - Tanaka, Ayako

AU - Takano, Kei

AU - Tashiro, Etsu

AU - Igarashi, Yasuhiro

AU - Imoto, Masaya

PY - 2014

Y1 - 2014

N2 - Cell migration is an essential step for tumor metastasis. The small GTPase Rac1 plays an important role in cell migration. Previously, we reported that epidermal growth factor (EGF) induced two waves of Rac1 activation; namely, at 5 min and 12 h after stimulation. A second wave of EGF-induced Rac1 activation was required for EGF-induced cell migration, however, the spatiotemporal regulation of the second wave of EGF-induced Rac1 activation remains largely unclear. In this study, we found that 5-lipoxygenase (5-LOX) is activated in the process of EGF-induced cell migration, and that leukotriene C4 (LTC4) produced by 5-LOX mediated the second wave of Rac1 activation, as well as cell migration. Furthermore, these effects caused by LTC4 were found to be blocked in the presence of the antagonist of cysteinyl leukotriene receptor 1 (CysLT1). This blockage indicates that LTC4-mediated CysLT1 signaling regulates the second EGF-induced wave of Rac1 activation. We also found that 5-LOX inhibitors, CysLT1 antagonists and the knockdown of CysLT1 inhibited EGF-induced T cell lymphoma invasion and metastasis-inducing protein 1 (Tiam1) expression. Tiam1 expression is required for the second wave of EGF-induced Rac1 activation in A431 cells. Therefore, our results indicate that the 5-LOX/LTC4/CysLT1 signaling pathway regulates EGF-induced cell migration by increasing Tiam1 expression, leading to a second wave of Rac1 activation. Thus, CysLT1 may serve as a new molecular target for antimetastatic therapy. In addition, the CysLT1 antagonist, montelukast, which is used clinically for allergy treatment, might have great potential as a novel type of antimetastatic agent. 5-lipoxygenase (5-LOX) is activated in the process of EGF-induced cell migration, and that leukotriene C4 (LTC4) produced by 5-LOX mediated Rac1 activation and cell migration. LTC4-mediated CysLT1 signaling regulates Tiam1 expression which is required for Rac1 activation.

AB - Cell migration is an essential step for tumor metastasis. The small GTPase Rac1 plays an important role in cell migration. Previously, we reported that epidermal growth factor (EGF) induced two waves of Rac1 activation; namely, at 5 min and 12 h after stimulation. A second wave of EGF-induced Rac1 activation was required for EGF-induced cell migration, however, the spatiotemporal regulation of the second wave of EGF-induced Rac1 activation remains largely unclear. In this study, we found that 5-lipoxygenase (5-LOX) is activated in the process of EGF-induced cell migration, and that leukotriene C4 (LTC4) produced by 5-LOX mediated the second wave of Rac1 activation, as well as cell migration. Furthermore, these effects caused by LTC4 were found to be blocked in the presence of the antagonist of cysteinyl leukotriene receptor 1 (CysLT1). This blockage indicates that LTC4-mediated CysLT1 signaling regulates the second EGF-induced wave of Rac1 activation. We also found that 5-LOX inhibitors, CysLT1 antagonists and the knockdown of CysLT1 inhibited EGF-induced T cell lymphoma invasion and metastasis-inducing protein 1 (Tiam1) expression. Tiam1 expression is required for the second wave of EGF-induced Rac1 activation in A431 cells. Therefore, our results indicate that the 5-LOX/LTC4/CysLT1 signaling pathway regulates EGF-induced cell migration by increasing Tiam1 expression, leading to a second wave of Rac1 activation. Thus, CysLT1 may serve as a new molecular target for antimetastatic therapy. In addition, the CysLT1 antagonist, montelukast, which is used clinically for allergy treatment, might have great potential as a novel type of antimetastatic agent. 5-lipoxygenase (5-LOX) is activated in the process of EGF-induced cell migration, and that leukotriene C4 (LTC4) produced by 5-LOX mediated Rac1 activation and cell migration. LTC4-mediated CysLT1 signaling regulates Tiam1 expression which is required for Rac1 activation.

KW - 5-Lipoxygenase

KW - Cell migration

KW - Cysteinyl leukotriene receptor 1

KW - Epidermal growth factor signaling

KW - T-cell lymphoma invasion and metastasis-inducing protein 1

UR - http://www.scopus.com/inward/record.url?scp=84895540162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895540162&partnerID=8YFLogxK

U2 - 10.1111/cas.12340

DO - 10.1111/cas.12340

M3 - Article

C2 - 24350867

AN - SCOPUS:84895540162

VL - 105

SP - 290

EP - 296

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 3

ER -